title: Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletion.
authors.forename: N C
authors.initials: NC
authors.lastname: Venn
authors.forename: V H J
authors.initials: VH
authors.lastname: van der Velden
authors.forename: M
authors.initials: M
authors.lastname: de Bie
authors.forename: E
authors.initials: E
authors.lastname: Waanders
authors.forename: J E
authors.initials: JE
authors.lastname: Giles
authors.forename: T
authors.initials: T
authors.lastname: Law
authors.forename: R P
authors.initials: RP
authors.lastname: Kuiper
authors.forename: V
authors.initials: V
authors.lastname: de Haas
authors.forename: C G
authors.initials: CG
authors.lastname: Mullighan
authors.forename: M
authors.initials: M
authors.lastname: Haber
authors.forename: G M
authors.initials: GM
authors.lastname: Marshall
authors.forename: Norris
authors.initials: N
authors.lastname: Md
authors.forename: J J M
authors.initials: JJ
authors.lastname: van Dongen
authors.forename: R
authors.initials: R
authors.lastname: Sutton
mesh_terms: D004273:DNA, Neoplasm / Q000235:genetics; D005240:Feasibility Studies; D006801:Humans; D051740:Ikaros Transcription Factor / Q000235:genetics*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000235:genetics; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000235:genetics*; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000503:physiopathology* / Q000628:therapy; D011237:Predictive Value of Tests; D018570:Risk Assessment; D017384:Sequence Deletion
chemical_list: D004273:DNA, Neoplasm; C497239:IKZF1 protein, human; D051740:Ikaros Transcription Factor